|
1 Company |
|
2 Products |
|
2 Products |
|
2 Mechanisms of Action |
|
0 Trials |
|
13 News |
|
- | Enrollment change, Trial termination: Evaluating Genetic Risk Factors for Childhood-Onset Schizophrenia (clinicaltrials.gov) - Oct 12, 2017
P=N/A, N=1556, Terminated, Sponsor: National Institute of Mental Health (NIMH)
N=1975 --> 1556 | Recruiting --> Terminated
- | Trial termination: Screening for Childhood-Onset Psychotic Disorders (clinicaltrials.gov) - Oct 9, 2017
P=N/A, N=123, Terminated, Sponsor: National Institute of Mental Health (NIMH)
N=1975 --> 1556 | Recruiting --> Terminated Completed --> Terminated
- | Trial completion: Screening for Childhood-Onset Psychotic Disorders (clinicaltrials.gov) - Sep 21, 2017
P=N/A, N=123, Completed, Sponsor: National Institute of Mental Health (NIMH)
Completed --> Terminated Active, not recruiting --> Completed
- | Trial primary completion date: Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia (clinicaltrials.gov) - Jul 7, 2017
P1/2, N=18, Terminated, Sponsor: National Institute of Mental Health (NIMH)
Active, not recruiting --> Completed Trial primary completion date: Jul 2017 --> Jun 2016
- Enrollment closed, Enrollment change: Screening for Childhood-Onset Psychotic Disorders (clinicaltrials.gov) - Nov 3, 2016
P=N/A, N=123, Active, not recruiting, Sponsor: National Institute of Mental Health (NIMH)
Trial primary completion date: Jul 2017 --> Jun 2016 Recruiting --> Active, not recruiting | N=250 --> 123
- Enrollment change, Trial termination: Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia (clinicaltrials.gov) - Jun 23, 2016
P1/2, N=18, Terminated, Sponsor: National Institute of Mental Health (NIMH)
Recruiting --> Active, not recruiting | N=250 --> 123 N=72 --> 18 | Recruiting --> Terminated
- Trial primary completion date: Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia (clinicaltrials.gov) - Aug 14, 2015
P1/2, N=72, Recruiting, Sponsor: National Institute of Mental Health (NIMH)
N=72 --> 18 | Recruiting --> Terminated Trial primary completion date: Jul 2015 --> Jul 2017
- Trial primary completion date: Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia (clinicaltrials.gov) - Jun 11, 2015
P1/2, N=72, Recruiting, Sponsor: National Institute of Mental Health (NIMH)
Trial primary completion date: Jul 2015 --> Jul 2017 Trial primary completion date: Jul 2017 --> Jul 2015
- Trial primary completion date: Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia (clinicaltrials.gov) - Jun 26, 2014
P1/2, N=72, Recruiting, Sponsor: National Institute of Mental Health (NIMH)
Trial primary completion date: Jul 2017 --> Jul 2015 Trial primary completion date: Jul 2016 --> Jul 2017
- | olanzapine / Generic mfg., clozapine / Generic mfg.
Trial completion: Treating Drug-Resistant Childhood Schizophrenia (clinicaltrials.gov) - Feb 22, 2014
P4, N=41, Completed, Sponsor: North Shore Long Island Jewish Health System
Trial primary completion date: Jul 2016 --> Jul 2017 Recruiting --> Completed
- | olanzapine / Generic mfg., clozapine / Generic mfg.
Trial completion: Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic Disorders (clinicaltrials.gov) - Feb 19, 2014
P4, N=25, Completed, Sponsor: National Institute of Mental Health (NIMH)
Recruiting --> Completed Active, not recruiting --> Completed
- | New P1/2 trial: Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia (clinicaltrials.gov) - Oct 21, 2012
P1/2, N=72, Recruiting, Sponsor: National Institute of Mental Health (NIMH)
- Enrollment change: Screening for Childhood-Onset Psychotic Disorders (clinicaltrials.gov) - Jan 18, 2012
P=N/A, N=250, Recruiting, Sponsor: National Institute of Mental Health (NIMH)
Active, not recruiting --> Completed N=150 --> 250